Molecular Design Using the Minireceptor Concept
暂无分享,去创建一个
James P. Snyder | Konrad F. Koehler | Johanna M. Jansen | Martin H. Hedberg | Anette M. Johansson | Uli Hacksell | Gunnar Nordvall | J. Snyder | U. Hacksell | K. Koehler | J. Jansen | G. Nordvall | A. Johansson | M. Hedberg
[1] D. Kingston,et al. Taxol: the chemistry and structure-activity relationships of a novel anticancer agent. , 1994, Trends in biotechnology.
[2] James P. Snyder,et al. Pseudoreceptor Modeling: The Construction of Three-Dimensional Receptor Surrogates , 1995 .
[3] I. Ringel,et al. 3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin. , 1994, The Journal of biological chemistry.
[4] P. Schiff,et al. Taxol stabilizes microtubules in mouse fibroblast cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[5] B. Gillet,et al. Conformation of Taxotere® and analogues determined by NMR spectroscopy and molecular modeling studies , 1993 .
[6] R. Himes,et al. Synthesis of a photoaffinity taxol analogue and its use in labeling tubulin. , 1994, Journal of medicinal chemistry.
[7] H. Williams,et al. NMR and molecular modeling study of the conformations of taxol and of its side chain methylester in aqueous and non-aqueous solution. , 1993 .
[8] D. Kingston,et al. The chemistry of taxol. , 1991, Pharmacology & therapeutics.
[9] D Rognan,et al. A pseudo-particle approach for studying protein-ligand models truncated to their active sites. , 1998, Biopolymers.
[10] S. Hjorth,et al. 10-substituted 11-oxygenated (R)-aporphines: synthesis, pharmacology, and modeling of 5-HT1A receptor interactions. , 1996, Journal of medicinal chemistry.
[11] D. Guénard,et al. Taxol and Taxotere: Discovery, Chemistry, and Structure‐Activity Relationships , 1993 .
[12] U. Hacksell,et al. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors. , 1994, Molecular pharmacology.
[13] M. Houslay. G‐protein linked receptors: a family probed by molecular cloning and mutagenesis procedures , 1992, Clinical endocrinology.
[14] D. E. Clark,et al. PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores. , 1994, Journal of medicinal chemistry.
[15] D. Gibson,et al. Photocyclization of aryl-substituted acetylenesi application of di-.pi.-methane-like rearrangements to arylcyclopropene syntheses , 1971 .
[16] H. Williams,et al. NMR and molecular modeling study of active and inactive taxol analogues in aqueous and nonaqueous solution , 1994 .
[17] A. Vedani,et al. Pseudo-receptor modeling: a new concept for the three-dimensional construction of receptor binding sites. , 1993, Journal of receptor research.
[18] M. Hamon. Neuropharmacology of anxiety: perspectives and prospects. , 1994, Trends in pharmacological sciences.
[19] Y. Martin,et al. 3D database searching in drug design. , 1992, Journal of medicinal chemistry.
[20] J Hoflack,et al. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.
[21] Richard Henderson,et al. A model for the structure of bacteriorhodopsin based on high resolution electron cryomicroscopy , 1990 .
[22] B. Max. This and that: sequential theories for stomach cancer and the multiple applications of isotopic ratios. , 1992, Trends in pharmacological sciences.
[23] J J Baldwin,et al. Application of the three-dimensional structures of protein target molecules in structure-based drug design. , 1994, Journal of medicinal chemistry.
[24] U. Hacksell,et al. Binding-site modeling of the muscarinic m1 receptor: a combination of homology-based and indirect approaches. , 1993, Journal of medicinal chemistry.
[25] R. Henderson,et al. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.
[26] B. Matthews,et al. Molecular basis of thermostability in the lysozyme from bacteriophage T4 , 1979, Nature.
[27] S. Hjorth,et al. (R)-11-hydroxy- and (R)-11-hydroxy-10-methylaporphine: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions. , 1995, Journal of medicinal chemistry.
[28] James B. Dunbar,et al. Chapter 29. 3D Database Searching and Docking Strategles , 1993 .
[29] S. Fesik,et al. NMR studies of molecular complexes as a tool in drug design. , 1991, Journal of medicinal chemistry.
[30] J. Jansen,et al. The high affinity melationin binding site probed with conformationally restricted ligand--I. Pharmacophore and minireceptor models. , 1996, Bioorganic & medicinal chemistry.
[31] Garland R. Marshall,et al. The Conformational Parameter in Drug Design: The Active Analog Approach , 1979 .
[32] S. Horwitz,et al. Mechanism of action of taxol. , 1992, Trends in pharmacological sciences.
[33] Andrew R. Leach,et al. Current methods for site-directed structure generation , 1994, J. Comput. Aided Mol. Des..
[34] C. Fraser,et al. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.
[35] C. Humblet,et al. Chapter 30. Three-dimensional Models of G-Protein Coupled Receptors , 1992 .
[36] D. Rognan,et al. MD simulations in Pseudo-Particle Fluids: Applications to active-site Protein Complexes , 1995 .
[37] A. McPhail,et al. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.
[38] J Hoflack,et al. Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. , 1992, Journal of medicinal chemistry.
[39] Angelo Vedani,et al. A new force field for modeling metalloproteins , 1990 .
[40] J. Taylor‐Papadimitriou,et al. Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. , 1994, Trends in biotechnology.
[41] P. Schiff,et al. Promotion of microtubule assembly in vitro by taxol , 1979, Nature.
[42] M. Suffness,et al. Chapter 32. Taxol: From Discovery to Therapeutic Use , 1993 .